Newsletter
2 de October de 2023
WTR – Brazil: Economic success matched by a surge in counterfeiting
Please read the article titled ‘Brazil: Economic success matched by a surge in counterfeiting,’ published on WTR and authored by Rafael Lacaz and Raquel Bastos, Partner and Head of our Anti-Counterfeiting team, respectively.
The article focuses on the growth of the Brazilian market, accompanied by an increase in counterfeiting. Consequently, it is crucial to enforce intellectual property rights, a task that demands careful planning, advanced technology, intelligence, training, and coordination. This effort is supported by various laws, treaties, and constitutional, civil, criminal, and procedural codes.
Collaboration with official anti-counterfeiting agencies and financial services companies is indispensable for the successful implementation and maintenance of an anti-counterfeiting program. That’s why, at Kasznar Leonardos, our goal is to ensure that your company can actively participate in this dialogue by forming alliances or associations dedicated to combating counterfeiting. You can count on us!
Read the full article here.
Last related news
4 de November de 2025
ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025
The proposal for reviewing the regulation concerning the general labeling of packaged foods (including beverages, ingredients, additives, and processing aids) was published … ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025
20 de October de 2025
Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age
Last month, Brazil took a major step toward regulating the digital environment for children and adolescents with the enactment of the ECA … Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age
17 de October de 2025
New Rules for Clinical Research: Federal Government Bets on Regulation to Boost Innovation and Investment
Brazil, despite being among the top 20 countries in terms of the number of clinical trials, contributes less than 2% of global … New Rules for Clinical Research: Federal Government Bets on Regulation to Boost Innovation and Investment